论文信息 - Comparison of modified (m)RECISTand RECIST 1.1 assessments in the phase 3 RESORCE trial comparing regorafenib and placebo in patients with hepatocellular carcinoma who progressed during sorafenib treatment - 字舞流文

Comparison of modified (m)RECISTand RECIST 1.1 assessments in the phase 3 RESORCE trial comparing regorafenib and placebo in patients with hepatocellular carcinoma who progressed during sorafenib treatment

M. Kudo | J. Bruix | G. Bodoky | G. Meinhardt | P. Ross | Yi‐Hsiang Huang | A. Granito | G. Han | G. Masi | S. Qin | O. Rosmorduc | T. Song | R. Gérolami | P. Merle | M. Leberre | M. Pracht | V. Breder | J. Bronowicki | I. Ollivier-Hourmand | A. Baumhauer | Yokosuka